Ibu-Lysin (Ibuprofen Lysine)

Ibuprofen lysine works by non‑selectively inhibiting the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which blocks the formation of prostaglandins that mediate pain, inflammation, and fever. The lysine salt improves solubility, allowing faster oral absorption.

The appropriate dose of Ibu-Lysin is determined by the prescribing clinician based on the patient’s condition, age, weight, and renal or hepatic status. Dosage instructions are provided on the prescription label and should not be altered without medical guidance.

Ibu-Lysin is generally avoided in the third trimester of pregnancy because NSAIDs can affect fetal cardiovascular development. Use during the first two trimesters should be under strict medical supervision, and breastfeeding mothers should consult a healthcare professional before use.

To order Ibu-Lysin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with standard ibuprofen tablets, ibuprofen lysine offers faster dissolution and quicker onset of action due to its higher solubility. Efficacy for pain and fever is similar, but the rapid absorption may be advantageous when prompt relief is desired.

Ibu-Lysin tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Ibu-Lysin is taken orally, usually with a full glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal irritation. Follow the prescribing clinician’s instructions for timing and frequency.

The most serious risks include severe gastrointestinal bleeding or ulceration, allergic reactions such as anaphylaxis, and renal impairment, especially in patients with pre‑existing kidney disease or dehydration. Prompt medical attention is required if any of these events occur.

Ibu-Lysin should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding, severe renal or hepatic impairment, and pregnant women in the third trimester. Patients on anticoagulant therapy should use it only under medical supervision.